Loading...
review article
Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014
Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers are very productive. The review on Drugs interacting with Enzymes was accepted in August 2012. However, this field is very dynamic. New potential targets for the treatment of Alzheimer's disease were identified. This update describes drugs interacting with 60 enzymes versus 43 enzymes in the first paper. Some compounds progressed in their development, while many others were discontinued. The present review covers the evolution of research in this field through April 2014.
Type
review article
Web of Science ID
WOS:000340487200001
Authors
Publication date
2014
Publisher
Published in
Volume
42
Issue
1
Start page
1
End page
68
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
October 23, 2014
Use this identifier to reference this record